Characteristics of patients with and without erosive and deforming disease
| Variables | Erosive disease n=32 | Non-erosive disease n=39 | p Value |
|---|---|---|---|
| DIP, distal interphalangeal joint; HAQ, Health Assessment Questionnaire; DMARDs, disease modifying antirheumatic drugs. | |||
| Age (years (SD)) | 48 (11) | 46 (12) | NS |
| Age at psoriasis onset (years (SD)) | 28 (10) | 26 (11) | NS |
| Age at arthritis onset (years (SD)) | 36 (9) | 38 (10) | NS |
| Psoriasis duration (years (SD)) | 18 (11) | 19 (10) | NS |
| Arthritis duration (months (SD)) | 8 (7) | 10 (6) | NS |
| Family history (%) | 19 | 23 | NS |
| Psoriasis first (%) | 72 | 77 | NS |
| Male to female ratio | 1 | 2.5 | 0.05 |
| Polyarthritis (%) | 73 | 27 | 0.0001 |
| Axial disease (%) | 43 | 57 | NS |
| Oligoarthritis (%) | 43 | 57 | NS |
| DIP disease (%) | 62 | 36 | 0.048 |
| Onychopathy (%) | 62 | 49 | NS |
| HLA-B27 (%) | 22 | 46 | 0.05 |
| HLA-Cw*0602 (%) | 50 | 56 | NS |
| HAQ (mean (SD)) | 1.2 (0.3) | 0.6 (0.4) | 0.012 |
| ACR class III and IV (%) | 19 | 8 | 0.036 |
| DMARD use (%) | 69 | 64 | NS |
| Corticosteroid use (%) | 47 | 44 | NS |